Sandoz Sues Watson, Amphastar Over Generic Lovenox
Patent owner Momenta and exclusive licensee Sandoz targeted Watson, Amphastar and Amphastar unit International Medication Systems Ltd., seeking “up to treble damages” as well as preliminary and permanent injunctions. The complaint accuses Amphastar and IMS of making their generic using methods covered by the patents-in-suit.
Already a subscriber? Click here to login